Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00505544 · ClinicalTrials.gov registry record
Measuring Sleep Disturbance Among Cancer Patients
A clinical trial of Advanced Cancer, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- 459
- Enrollment target
- 2
- Study locations
NCT00505544 is a study of Advanced Cancer that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 459 participants, above the 243-participant average among 122 other Advanced Cancer trials with a reported enrollment target (89% higher). The trial reports 2 study locations across 1 state.
The verdict
NCT00505544, a study of Advanced Cancer, has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- 459 participants
- Enrollment target
- 2
- Study locations
Study Summary
Objectives: Primary Objectives: 1. To establish concurrent criterion-related validity of the Brief Sleep Disturbance Scale (BSDS) by correlating the scale with the Pittsburgh Sleep Quality Index. 2. To evaluate the construct validity of the BSDS through exploratory factor analysis. 3. To examine possible predictors of sleep disturbance. 4. To evaluate the reliability of the BSDS using Cronbach's coefficient alpha and test-retest reliability. 5. To evaluate the sensitivity of the BSDS by administering it to the same group of patients (n = 60) prior to treatment with a regimen associated with sleep disturbance, during 4 weeks of treatment, and upon completion of treatment. 6. To evaluate the psychometric properties of the BSDS in a sample of community dwelling adults. Secondary Objective: 1\. To obtain pilot data from a small sample of patients who will wear an actigraph for one week.
Conditions Studied
Interventions
- BEHAVIORAL Questionnaire
- DEVICE Actigraph
Study Locations (2)
Texas
- Lyndon Baines Johnson General Hospital - Houston
- University of Texas MD Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 459 participants |
| Start Date | 2005-08 |
| Est. Completion | 2022-07-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00505544
The ClinicalTrials.gov registry entry for NCT00505544 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 459 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 243-participant average among 122 other Advanced Cancer trials with a reported enrollment target (89% higher). The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Advanced Cancer appearing as the primary indexed condition, and to 2 interventions - of which Questionnaire is the first listed.
NCT00505544 reports 2 study locations spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT00505544 about?
NCT00505544 is a clinical study titled "Measuring Sleep Disturbance Among Cancer Patients". Objectives: Primary Objectives: 1. To establish concurrent criterion-related validity of the Brief Sleep Disturbance Scale (BSDS) by correlating the scale with the Pittsburgh Sleep Quality Index. 2. To evaluate the construct validity of the BSDS through exploratory factor analysis. 3. To examine p...
What is the current status of trial NCT00505544?
This trial is currently completed. The enrollment target is 459 participants. The study started on 2005-08. Estimated completion is 2022-07-11.
What conditions does trial NCT00505544 study?
This clinical trial studies the following conditions: Advanced Cancer.
What interventions are being tested in trial NCT00505544?
The interventions under investigation include: Questionnaire (BEHAVIORAL), Actigraph (DEVICE).
Who is sponsoring clinical trial NCT00505544?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00505544 being conducted?
This trial has 2 study locations across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Advanced Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Evaluating Disparities in Precision Oncology
RECRUITING
-
BOLSTER: Learning New Skills to Thrive
RECRUITING · NA
-
Givastomig Combined With Nivolumab and Chemotherapy in Adults With CLDN18.2 Positive Metastatic Gastric Cancer (GIVA-2)
RECRUITING · Phase 2
-
Longitudinal Screening for Financial Hardship to Improve Outcomes in Patients With Advanced Cancer
RECRUITING · NA
-
Phase 1b Trial of BMS-986504 in Combination With Olaparib in Patients With MTAP Loss
RECRUITING · Phase 1
-
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.